APA

Zurfluh S., Baumgartner T., Meier M. A., Ottiger M., Voegeli A., Bernasconi L., Neyer P., Mueller B. & Schuetz P. (20181025). The role of metabolomic markers for patients with infectious diseases: implications for risk stratification and therapeutic modulation. : Expert review of anti-infective therapy.

Chicago

Zurfluh Seline, Baumgartner Thomas, Meier Marc A, Ottiger Manuel, Voegeli Alaadin, Bernasconi Luca, Neyer Peter, Mueller Beat and Schuetz Philipp. 20181025. The role of metabolomic markers for patients with infectious diseases: implications for risk stratification and therapeutic modulation. : Expert review of anti-infective therapy.

Harvard

Zurfluh S., Baumgartner T., Meier M. A., Ottiger M., Voegeli A., Bernasconi L., Neyer P., Mueller B. and Schuetz P. (20181025). The role of metabolomic markers for patients with infectious diseases: implications for risk stratification and therapeutic modulation. : Expert review of anti-infective therapy.

MLA

Zurfluh Seline, Baumgartner Thomas, Meier Marc A, Ottiger Manuel, Voegeli Alaadin, Bernasconi Luca, Neyer Peter, Mueller Beat and Schuetz Philipp. The role of metabolomic markers for patients with infectious diseases: implications for risk stratification and therapeutic modulation. : Expert review of anti-infective therapy. 20181025.